Serology-based therapeutic strategy in SARS-CoV-2-infected patients
SARS-CoV-2 감염 환자의 혈청학 기반 치료 전략
Article
[키워드] Admission
anti-inflammatory treatment
antibody
B cell
benefit
convalescent plasma
Convalescent plasma therapy
COVID-19
Dexamethasone
disease
early administration
elderly patients
High-dose
Hospitalization
immune response
immunological
Immunosuppressed
Immunotherapy
impair
individual
Infection
intensive care
life-threatening
lung damage
lymphocyte
lymphoid
NK cell
not affect
Patient
patients
patients with SARS-CoV-2
plasma
positive serology
presence of antibody
progression
receive
required
SARS-CoV-2
SARS-CoV-2-infected patient
serology
T cell
T cells
the patient
the SARS-CoV-2 virus
therapeutic strategy
therapy
Tocilizumab
Treatment
virus
[DOI] 10.1016/j.intimp.2021.108214 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.intimp.2021.108214 PMC 바로가기 [Article Type] Article